enGene Holdings Inc. (ENGN) Key Metrics

NASDAQ: ENGNValuation, returns, debt and efficiency ratios over 6 years.

ENGN valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$111.9M
Enterprise value
−$98.3M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
—
Price / book
0.6
10-yr median 1.8
EV / EBITDA
—
Dividend yield
—
Beta
−0.28

ENGN key metrics, FY2020–FY2025

Fiscal year ended October 31, 2025 · U.S. dollars

ENGN valuation Price multiples at each fiscal year-end price.

Price / book+51.7%
2.2
FY2025 · hover or tap a bar for each year
FY2022: 1.3FY2023: 7.1 (+459.7%)FY2024: 1.4 (−79.4%)FY2025: 2.2 (+51.7%)
FY2020FY2025
Free cash flow yield−14.9 pts
−27.3%
FY2025 · hover or tap a bar for each year
FY2022: −11.1%FY2023: −4.9% (+6.2 pts)FY2024: −12.5% (−7.6 pts)FY2025: −27.3% (−14.9 pts)
FY2020FY2025

ENGN valuation history

Fiscal year-endToday6-year median

ENGN returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

ENGN debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

ENGN price vs earnings per share

Share price at year-endEPS (right axis)

ENGN key metrics

FY2020–FY2025
enGene Holdings Inc. key metrics by fiscal year
FY2025FY2024FY2023FY2022FY2021FY2020
Valuation
Market capitalization$368.6M$395.0M$511.1M$160.5M——
Enterprise value$206.6M$181.7M$439.3M$192.3M——
Price / book2.21.47.11.3——
Earnings yield−31.8%−14.0%−19.6%−15.2%——
Free cash flow yield−27.3%−12.5%−4.9%−11.1%——
Share price at fiscal year-end$7.21$8.85$21.70$10.15——
Per share
Revenue per share$0.00$0.00$0.00$0.00$0.00$0.00
Earnings per share−$2.29−$1.24−$4.24−$1.55−$1.48−$0.95
Operating cash flow per share−$1.94−$1.08−$1.05−$1.11−$1.01−$0.83
Free cash flow per share−$1.97−$1.10−$1.06−$1.12−$1.03−$0.84
Cash per share$3.79$5.34$3.46$0.02$0.07—
Book value per share$3.28$6.11$3.08$8.06$8.06—
Tangible book value per share$3.28$6.11$3.08$8.06$8.06—
Capex per share$0.03$0.02$0.01$0.01$0.02$0.01
Debt per share$0.62$0.56$0.42$2.03$0.26—
Shares outstanding51.1M44.6M23.6M15.8M15.8M15.8M
Change in shares outstanding+14.5%+89.5%+49.0%0.0%0.0%—
Returns & profitability
Return on equity (ROE)−53.3%−32.0%−100.0%−19.2%−18.4%—
Return on invested capital (ROIC)−299.8%−164.3%−25.8%−10.6%−9.6%—
Return on assets (ROA)−44.0%−27.7%−91.2%−18.6%−17.8%—
Return on tangible assets−53.0%−17.7%−114.9%−18.5%−17.8%—
Financial health
Total debt$31.8M$25.0M$9.8M$32.1M$4.2M—
Cash & short-term investments$193.8M$238.4M$81.6M$314,151$1.1M—
Net debt−$162.0M−$213.4M−$71.8M$31.8M$3.1M—
Debt / equity0.190.090.130.250.03—
Debt / assets0.140.080.110.240.03—
Current ratio6.3016.8716.250.574.79—
Quick ratio6.3016.8716.240.494.54—
Interest coverage-41.1-22.3-5.3-13.7-3.2-3.7
Working capital$169.4M$232.7M$80.2M−$381,705$1.2M—
Invested capital$5.7M$59.2M$667,000$159.2M$130.5M—
Tangible asset value$167.7M$272.6M$72.5M$127.4M$127.4M—
Net current asset value$147.6M$208.8M$71.0M−$4.1M−$2.5M—
Graham net-net per share$2.77$4.49$2.93−$0.21−$0.11—
Capital allocation
Capex / depreciation2.922.861.820.640.910.74
Efficiency
Days of inventory on hand——156.4———
Days payables outstanding2,903.91,450.41,959.5———
Receivables turnover0.000.000.000.000.00—
Payables turnover0.130.250.19———
Inventory turnover——2.33———
Asset turnover0.000.000.000.000.00—
Average receivables$1.6M$1.7M$1.8M$1.5M$1.6M—
Average payables$4.0M$1.3M$939,500$862,000$1.0M—
Average inventory——$75,000$77,500$81,000—
Intangibles / total assets0.0%0.0%0.0%0.0%0.0%—

Computed from ENGN's annual financial statements (latest annual report filed December 22, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

ENGN valuation and financial ratios

enGene earned a return on equity of −53.3% and a return on invested capital of −299.8% in fiscal 2025. It ended the year with $31.8 million of debt and $193.8 million in cash and short-term investments, a net cash position of $162.0 million. The share count rose 223.3% from 15.8M to 51.1M over 5 years.

See the ENGN income statement, the ENGN chart for price history, or the ENGN stock overview for the latest quote and news.

ENGN key metrics FAQ

What is enGene's return on equity?

enGene's return on equity (ROE) was −53.3% in fiscal 2025: net income of -$117.3 million on average shareholders' equity of $220.2 million.

What is enGene's ROIC?

enGene's return on invested capital was −299.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does enGene have?

enGene had total debt of $31.8 million at the end of fiscal 2025, a debt-to-equity ratio of 0.19 and more cash than debt.

What is enGene's free cash flow yield?

enGene generated -$100.7 million of free cash flow in fiscal 2025, a free cash flow yield of −27.3% on its market value at year-end ($368.6 million).

What is enGene's current ratio?

enGene's current ratio was 6.30 at the end of fiscal 2025: current assets were 6.30 times current liabilities.

Biotechnology key metrics